Low-level light therapy of the eye and brain

Area of Science:

• Photobiology and bioenergetics
• Neuroscience
• Ophthalmology

Background:

• Low-level light therapy (LLLT) is emerging as a therapeutic modality with applications in ophthalmology, neurology, and psychiatry.
• Progress in photobiology and bioenergetics underpins the therapeutic potential of LLLT.
• LLLT's mechanisms involve molecular, cellular, and nervous tissue interactions.

Purpose of the Study:

• To describe the mechanisms of action of LLLT.
• To review LLLT's therapeutic potential in various neurological and visual conditions.
• To present current knowledge on LLLT dosimetry for nervous tissue.

Main Methods:

• Focus on photoneuromodulation of cytochrome oxidase as the primary mechanism.
• Review of evidence for LLLT's effects on mitochondrial function, neural metabolism, and redox states.
• Presentation of in vivo noninvasive retinal and transcranial LLLT dosimetry and effects.

Main Results:

• LLLT modulates cytochrome oxidase, a key mitochondrial enzyme in nerve cells.
• LLLT enhances neural metabolism, antioxidant effects, and cerebral blood flow.
• Studies support LLLT benefits for retinal disease, stroke, neurodegeneration, and mood disorders.

Conclusions:

• LLLT offers a novel therapeutic paradigm for visual, neurological, and psychological conditions.
• Targeting neuronal energy metabolism with LLLT shows significant potential for eye and brain neurotherapeutics.
• LLLT demonstrates beneficial effects without adverse events at therapeutic energy densities.